Search

Rigel Pharmaceuticals Inc

Slēgts

SektorsVeselības aprūpe

40.02 2.17

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

37.28

Max

39.17

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+58.51% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. aug.

Ziņu noskaņojums

By Acuity

67%

33%

291 / 340 Rangs Healthcare

Rigel Pharmaceuticals Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 3. aug. 19:26 UTC

Rigel Pharmaceuticals Inc. is higher today, aligning with market trends as the S&P 500 and Nasdaq see gains amid improved investor sentiment.

2026. g. 31. jūl. 19:41 UTC

Rigel Pharmaceuticals is lower today amid significant downward pressure in the Biotechnology sub-sector, despite a slight recovery from session lows.

2026. g. 30. jūl. 19:29 UTC

Rigel Pharmaceuticals Inc shares are lower today amid unusual volatility, reaching a session low earlier after peaking shortly after the market opened.

2026. g. 29. jūl. 19:47 UTC

Rigel Pharmaceuticals Inc. is trading higher Wednesday, pulling back from earlier session highs amid mixed performance across major U.S. indices ahead of the Fed's decision.

2026. g. 28. jūl. 19:56 UTC

News

Rigel Pharmaceuticals shares are higher today as the company announced a conference call for its second quarter 2026 financial results on August 4.

2026. g. 27. jūl. 16:16 UTC

Rigel Pharmaceuticals is higher during Monday's session, rebounding after six days of declines. The stock remains up since Friday's close amid broader market dynamics.

2026. g. 24. jūl. 20:01 UTC

Rigel Pharmaceuticals Inc shares are higher today, recovering from earlier dips amid increased trading volume and broader market gains despite no specific news identified.

2026. g. 22. jūl. 20:06 UTC

Rigel Pharmaceuticals Inc shares are lower Wednesday amid ongoing market uncertainty ahead of the Federal Reserve meeting, with no specific news driving the decline.

2026. g. 21. jūl. 17:26 UTC

News

Rigel Pharmaceuticals Inc shares are higher, reflecting positive sentiment in the biotechnology sector amid broader market gains, particularly in technology stocks.

Salīdzinājums

Cenas izmaiņa

Rigel Pharmaceuticals Inc Prognoze

Cenas mērķis

By TipRanks

58.51% augšup

Prognoze 12 mēnešiem

Vidējais 59.33 USD  58.51%

Augstākais 81 USD

Zemākais 40 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Rigel Pharmaceuticals Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

3 ratings

2

Pirkt

1

Turēt

0

Pārdot

Noskaņojums

By Acuity

291 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

$

help-icon Live chat